Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation

EMBO Journal

Volumn 23, Issue 12, 2004, Pages 2402-2412

  Bhat, Krishna P ^a   Itahana, Koji ^a   Jin, Aiwen ^a   Zhang, Yanping ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Actinomycin D; HDM2; L11; p53; Serum starvation

Indexed keywords

DACTINOMYCIN; LIGASE; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53; RIBOSOMAL PROTEIN L11; RIBOSOME PROTEIN; RIBOSOME RNA; UNCLASSIFIED DRUG;

60S RIBOSOMAL SUBUNIT; ARTICLE; CELL GROWTH; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; RIBOSOME SUBUNIT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; RIBOSOMAL PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3242715867     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600247     Document Type: Article

References (40)

1. Allan LA, Fried M (1999) p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis. Oncogene 18: 5403-5412
2. Ashcroft M, Taya Y, Vousden KH (2000) Stress signals utilize multiple pathway, to stabilize p53. Mol Cell Biol 20: 3224-3233
3. Ashcroft M, Vousden KH (1999) Regulation of p53 stability. Oncogene 18: 7637-7643
4. Barak Y, Juven T, Haffner R, Oren M (1993) Mdm-2 expression is induced by wild-type p53 activity. EMBO J 12: 461-468
5. da Rocha AB, Lopes RM, Schwartsmann G (2001) Natural products in anticancer therapy. Curr Opin Pharmacol 1: 364-369
6. Du YC, Stillman B (2002) Yph1p, an ORC-interacting protein: potential links between cell proliferation control, DNA replication, and ribosome biogenesis. Cell 109: 835-848
7. Duncan R, McConkey EH (1982) Rapid alterations in initiation rate and recruitment of inactive RNA are temporally correlated with S6 phosphorylation. Eur J Biochem 123: 539-544
8. Giaccia AJ, Kastan MB (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12: 2973-2983
9. Harlow E, Lane D (1988) Antibodies: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press
10. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299
11. Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27
12. Iapalucci-Espinoza S, Franze-Fernandez MT (1979) Effect of protein synthesis inhibitors and low concentrations of actinomycin D on ribosomal RNA synthesis. FEBS Lett 107: 281-284
13. Itahana K, Dimri GP, Hara E, Itahana Y, Zou Y, Desprez PY, Campisi J (2002) A role for p53 in maintaining and establishing the quiescence growth arrest in human cells. J Biol Chem 277: 18206-18214
14. Kubbutat MHG, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303
15. Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM (1996) A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 10: 934-947
16. Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3: 577-587
17. Marechal V, Elenbaas B, Piette J, Nicolas J-C, Levine AJ (1994) The ribosomal protein L5 is associated with mdm-2 and mdm2-p53 complexes. Mol Cell Biol 14: 7414-7420
18. Meek DW (1999) Mechanisms of switching on p53: a role for covalent modification? Oncogene 18: 7666-7675
19. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245
20. Muramatsu M, Hayashi Y, Onishi T, Sakai M, Takai K (1974) Rapid isolation of nucleoli from detergent purified nuclei of various tumor and tissue culture cells. Exp Cell Res 88: 245-251
21. Perry RP, Kelley DE (1970) Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species. J Cell Physiol 76: 127-139
22. Pestka S (1974) The use of inhibitors in studies on protein synthesis. Methods Enzymol 30: 261-282
23. Pestov DG, Strezoska Z, Lau LF (2001) Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 21: 4246-4255
24. Rotenberg MO, Moritz M, Woolford Jr JL (1988) Depletion of Saccharomyces cerevisiae ribosomal protein L16 causes a decrease in 60S ribosomal subunits and formation of half-mer polyribosomes. Genes Dev 2: 160-172
25. Rubbi CP, Milner J (2003) Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 22: 6068-6077
26. Ruggero D, Pandolfi PP (2003) Does the ribosome translate cancer. Nat Rev Cancer 3: 179-192
27. Ryan KM, Phillips AC, Vousden KH (2001) Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13: 332-337
28. Scheer U, Hock R (1999) Structure and function of the nucleolus. Curr Opin Cell Biol 11: 385-390
29. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex function as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505
30. Sherr CJ, Weber JD (2000) The ARF-p53 pathway. Curr Opin Genet Dev 10: 94-99
31. Shieh S-Y, Ikeda M, Taya Y, Prives C (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334
32. Spector DL, Ochs RL, Busch H (1984) Silver staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23. Chromosoma 90: 139-148
33. Strezoska Z, Pestov DG, Lau LF (2000) Bop1 is a mouse WD40 repeat nucleolar protein involved in 28S and 5.8S rRNA processing and 60S ribosome biogenesis. Mol Cell Biol 20: 5516-5528
34. Thut CJ, Goodrich JA, Tjian R (1997) Repression of p53-mediated transcription by MDM2, a dual mechanism. Genes Dev 11: 1974-1986
35. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408: 307-310
36. Volarevic S, Stewart MJ, Ledermann B, Zilberman F, Terracciano L, Montini E, Grompe M, Kozma SC, Thomas G (2000) Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 288: 2045-2047
37. Wu X, Bayle JH, Olson D, Levine AJ (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7: 1126-1132
38. Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, Xiong Y (2003) Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23: 8902-8912
39. Zhang Y, Xiong Y (1999) Mutation in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol Cell 3: 579-591
40. Zhang Y, Xiong Y, Yarbrough WG (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734